Search Legislation

Advanced Search

Commission Implementing Regulation (EU) 2020/1995Show full title

Commission Implementing Regulation (EU) 2020/1995 of 4 December 2020 amending Implementing Regulation (EU) No 2018/1261 as regards administrative changes of the information related to the Union authorisation of the biocidal product family ‘Hypred’s iodine based products’ (Text with EEA relevance)

Help about what version

What Version

Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

This version of this Regulation was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Information:

You searched for provisions that are applicable to England. The matching provisions are highlighted below. Where no highlighting is shown the matching result may be contained within a footnote.

  1. Introductory TextNext Match

  2. Article 1.Implementing Regulation (EU) 2018/1261 is amended as follows: in Article...Previous MatchNext Match

  3. Article 2.This Regulation shall enter into force on the twentieth day...Previous MatchNext Match

  4. SignaturePrevious MatchNext Match

    1. ANNEXPrevious MatchNext Match

      Summary of product characteristics for a biocidal product family Previous MatchNext Match

      1. HYPRED's iodine based products Previous MatchNext Match

      2. Product type 3 - Veterinary hygiene (Disinfectants) Previous MatchNext Match

      3. Authorisation number: EU-0018397-0000 Previous MatchNext Match

      4. R4BP asset number: EU-0018397-0000 Previous MatchNext Match

      5. PART I FIRST INFORMATION LEVEL Previous MatchNext Match

        1. 1. ADMINISTRATIVE INFORMATION Previous MatchNext Match

          1. 1.1. Family name Previous MatchNext Match

          2. 1.2. Product type(s) Previous MatchNext Match

          3. 1.3. Authorisation holder Previous MatchNext Match

          4. 1.4. Manufacturer(s) of the biocidal products Previous MatchNext Match

          5. 1.5. Manufacturer(s) of the active substance(s) Previous MatchNext Match

        2. 2. PRODUCT FAMILY COMPOSITION AND FORMULATION Previous MatchNext Match

          1. 2.1. Qualitative and quantitative information on the composition of the family...Previous MatchNext Match

          2. 2.2. Type(s) of formulation Previous MatchNext Match

      6. PART II SECOND INFORMATION LEVEL - META SPC(S) Previous MatchNext Match

        1. META SPC 1 Previous MatchNext Match

          1. 1. META SPC 1 ADMINISTRATIVE INFORMATION Previous MatchNext Match

            1. 1.1. Meta SPC 1 identifier Previous MatchNext Match

            2. 1.2. Suffix to the authorisation number Previous MatchNext Match

            3. 1.3. Product type(s) Previous MatchNext Match

          2. 2. META SPC 1 COMPOSITION Previous MatchNext Match

            1. 2.1. Qualitative and quantitative information on the composition of the meta...Previous MatchNext Match

            2. 2.2. Type(s) of formulation of the meta SPC 1 Previous MatchNext Match

          3. 3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 1 Previous MatchNext Match

          4. 4. AUTHORISED USE(S) OF THE META SPC 1 Previous MatchNext Match

            1. 4.1. Use description Previous MatchNext Match

              1. 4.1.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.1.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.1.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.1.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.1.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

          5. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 1 Previous MatchNext Match

            1. 5.1. Instructions for use Previous MatchNext Match

            2. 5.2. Risk mitigation measures Previous MatchNext Match

            3. 5.3. Particulars of likely direct or indirect effects, first aid instructions...Previous MatchNext Match

            4. 5.4. Instructions for safe disposal of the product and its packaging...Previous MatchNext Match

            5. 5.5. Conditions of storage and shelf-life of the product under normal...Previous MatchNext Match

          6. 6. OTHER INFORMATION Previous MatchNext Match

          7. 7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 1...Previous MatchNext Match

            1. 7.1. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

            2. 7.2. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

        2. META SPC 2 Previous MatchNext Match

          1. 1. META SPC 2 ADMINISTRATIVE INFORMATION Previous MatchNext Match

            1. 1.1. Meta SPC 2 identifier Previous MatchNext Match

            2. 1.2. Suffix to the authorisation number Previous MatchNext Match

            3. 1.3. Product type(s) Previous MatchNext Match

          2. 2. META SPC 2 COMPOSITION Previous MatchNext Match

            1. 2.1. Qualitative and quantitative information on the composition of the meta...Previous MatchNext Match

            2. 2.2. Type(s) of formulation of the meta SPC 2 Previous MatchNext Match

          3. 3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 2 Previous MatchNext Match

          4. 4. AUTHORISED USE(S) OF THE META SPC 2 Previous MatchNext Match

            1. 4.1. Use description Previous MatchNext Match

              1. 4.1.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.1.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.1.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.1.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.1.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

            2. 4.2. Use description Previous MatchNext Match

              1. 4.2.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.2.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.2.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.2.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.2.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

          5. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 2 Previous MatchNext Match

            1. 5.1. Instructions for use Previous MatchNext Match

            2. 5.2. Risk mitigation measures Previous MatchNext Match

            3. 5.3. Particulars of likely direct or indirect effects, first aid instructions...Previous MatchNext Match

            4. 5.4. Instructions for safe disposal of the product and its packaging...Previous MatchNext Match

            5. 5.5. Conditions of storage and shelf-life of the product under normal...Previous MatchNext Match

          6. 6. OTHER INFORMATION Previous MatchNext Match

          7. 7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 2...Previous MatchNext Match

            1. 7.1. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

            2. 7.2. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

        3. META SPC 3 Previous MatchNext Match

          1. 1. META SPC 3 ADMINISTRATIVE INFORMATION Previous MatchNext Match

            1. 1.1. Meta SPC 3 identifier Previous MatchNext Match

            2. 1.2. Suffix to the authorisation number Previous MatchNext Match

            3. 1.3. Product type(s) Previous MatchNext Match

          2. 2. META SPC 3 COMPOSITION Previous MatchNext Match

            1. 2.1. Qualitative and quantitative information on the composition of the meta...Previous MatchNext Match

            2. 2.2. Type(s) of formulation of the meta SPC 3 Previous MatchNext Match

          3. 3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 3 Previous MatchNext Match

          4. 4. AUTHORISED USE(S) OF THE META SPC 3 Previous MatchNext Match

            1. 4.1. Use description Previous MatchNext Match

              1. 4.1.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.1.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.1.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.1.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.1.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

            2. 4.2. Use description Previous MatchNext Match

              1. 4.2.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.2.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.2.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.2.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.2.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

          5. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 3 Previous MatchNext Match

            1. 5.1. Instructions for use Previous MatchNext Match

            2. 5.2. Risk mitigation measures Previous MatchNext Match

            3. 5.3. Particulars of likely direct or indirect effects, first aid instructions...Previous MatchNext Match

            4. 5.4. Instructions for safe disposal of the product and its packaging...Previous MatchNext Match

            5. 5.5. Conditions of storage and shelf-life of the product under normal...Previous MatchNext Match

          6. 6. OTHER INFORMATION Previous MatchNext Match

          7. 7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 3...Previous MatchNext Match

            1. 7.1. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

        4. META SPC 4 Previous MatchNext Match

          1. 1. META SPC 4 ADMINISTRATIVE INFORMATION Previous MatchNext Match

            1. 1.1. Meta SPC 4 identifier Previous MatchNext Match

            2. 1.2. Suffix to the authorisation number Previous MatchNext Match

            3. 1.3. Product type(s) Previous MatchNext Match

          2. 2. META SPC 4 COMPOSITION Previous MatchNext Match

            1. 2.1. Qualitative and quantitative information on the composition of the meta...Previous MatchNext Match

            2. 2.2. Type(s) of formulation of the meta SPC 4 Previous MatchNext Match

          3. 3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 4 Previous MatchNext Match

          4. 4. AUTHORISED USE(S) OF THE META SPC 4 Previous MatchNext Match

            1. 4.1. Use description Previous MatchNext Match

              1. 4.1.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.1.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.1.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.1.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.1.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

          5. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 4 Previous MatchNext Match

            1. 5.1. Instructions for use Previous MatchNext Match

            2. 5.2. Risk mitigation measures Previous MatchNext Match

            3. 5.3. Particulars of likely direct or indirect effects, first aid instructions...Previous MatchNext Match

            4. 5.4. Instructions for safe disposal of the product and its packaging...Previous MatchNext Match

            5. 5.5. Conditions of storage and shelf-life of the product under normal...Previous MatchNext Match

          6. 6. OTHER INFORMATION Previous MatchNext Match

          7. 7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 4...Previous MatchNext Match

            1. 7.1. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

        5. META SPC 5 Previous MatchNext Match

          1. 1. META SPC 5 ADMINISTRATIVE INFORMATION Previous MatchNext Match

            1. 1.1. Meta SPC 5 identifier Previous MatchNext Match

            2. 1.2. Suffix to the authorisation number Previous MatchNext Match

            3. 1.3. Product type(s) Previous MatchNext Match

          2. 2. META SPC 5 COMPOSITION Previous MatchNext Match

            1. 2.1. Qualitative and quantitative information on the composition of the meta...Previous MatchNext Match

            2. 2.2. Type(s) of formulation of the meta SPC 5 Previous MatchNext Match

          3. 3. HAZARD AND PRECAUTIONARY STATEMENTS OF THE META SPC 5 Previous MatchNext Match

          4. 4. AUTHORISED USE(S) OF THE META SPC 5 Previous MatchNext Match

            1. 4.1. Use description Previous MatchNext Match

              1. 4.1.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.1.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.1.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.1.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.1.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

            2. 4.2. Use description Previous MatchNext Match

              1. 4.2.1. Use-specific instructions for use Previous MatchNext Match

              2. 4.2.2. Use-specific risk mitigation measures Previous MatchNext Match

              3. 4.2.3. Where specific to the use, the particulars of likely direct...Previous MatchNext Match

              4. 4.2.4. Where specific to the use, the instructions for safe disposal...Previous MatchNext Match

              5. 4.2.5. Where specific to the use, the conditions of storage and...Previous MatchNext Match

          5. 5. GENERAL DIRECTIONS FOR USE OF THE META SPC 5 Previous MatchNext Match

            1. 5.1. Instructions for use Previous MatchNext Match

            2. 5.2. Risk mitigation measures Previous MatchNext Match

            3. 5.3. Particulars of likely direct or indirect effects, first aid instructions...Previous MatchNext Match

            4. 5.4. Instructions for safe disposal of the product and its packaging...Previous MatchNext Match

            5. 5.5. Conditions of storage and shelf-life of the product under normal...Previous MatchNext Match

          6. 6. OTHER INFORMATION Previous MatchNext Match

          7. 7. THIRD INFORMATION LEVEL: INDIVIDUAL PRODUCTS IN THE META SPC 5...Previous MatchNext Match

            1. 7.1. Trade name(s), authorisation number and specific composition of each individual...Previous MatchNext Match

Back to top

Options/Help

Print Options

You have chosen to open the Whole Regulation

The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources

The data on this page is available in the alternative data formats listed: